William Valle's most recent trade in TriSalus Life Sciences Inc was a trade of 30,487 Common Stock done at an average price of $4.1 . Disclosure was reported to the exchange on Feb. 23, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| TriSalus Life Sciences Inc | William Valle | Director | Purchase of securities on an exchange or from another person at price $ 4.10 per share. | 23 Feb 2026 | 30,487 | 30,487 | - | 4.1 | 124,997 | Common Stock |
| TriSalus Life Sciences Inc | William Valle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 15,000 | 56,250 | - | - | Director Stock Option (right to buy) | |
| TriSalus Life Sciences Inc | William Valle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 35,000 | 35,000 | - | - | Director Stock Option (right to buy) | |
| TriSalus Life Sciences Inc | William Valle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 6,250 | 6,250 | - | - | Director Stock Option (right to buy) | |
| American Oncology Network Inc | William Valle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2024 | 14,981 | 14,981 | - | 0 | Class A Common Stock |